F. Tas Et Al. , "Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome," MOLECULAR AND CLINICAL ONCOLOGY , vol.4, no.4, pp.655-659, 2016
Tas, F. Et Al. 2016. Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome. MOLECULAR AND CLINICAL ONCOLOGY , vol.4, no.4 , 655-659.
Tas, F., Bılgın, E., Karabulut, S., Tastekın, D., & Duranyıldız, D., (2016). Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome. MOLECULAR AND CLINICAL ONCOLOGY , vol.4, no.4, 655-659.
Tas, Faruk Et Al. "Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome," MOLECULAR AND CLINICAL ONCOLOGY , vol.4, no.4, 655-659, 2016
Tas, Faruk Et Al. "Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome." MOLECULAR AND CLINICAL ONCOLOGY , vol.4, no.4, pp.655-659, 2016
Tas, F. Et Al. (2016) . "Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome." MOLECULAR AND CLINICAL ONCOLOGY , vol.4, no.4, pp.655-659.
@article{article, author={Faruk TAŞ Et Al. }, title={Levels of serum fibronectin as a biomarker in gastric cancer patients: Correlation with clinical diagnosis and outcome}, journal={MOLECULAR AND CLINICAL ONCOLOGY}, year=2016, pages={655-659} }